Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of diagnosing, treating and determining progression and survival of cancer cells using BCL-2 antagonist of cell death (BAD) pathway gene signature

Method of diagnosing, treating and determining progression and survival of cancer cells using BCL-2 antagonist of cell death (BAD) pathway gene signature

US Patent 9983209 · Granted May 29, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of distinguishing lung squamous cell carcinoma from head and neck squamou2023
Method of distinguishing urothelial carcinoma from lung and head and neck squamo2023
Compositions and methods APC, CREB, and BAD pathways to assess and affect cancer2021
Compositions and methods APC, CREB, and BAD pathways to assess and affect cancer2021
Method and system for data backup2018
O-glycan pathway ovarian cancer signature2017
O-glycan pathway ovarian cancer signature2017
O-glycan pathway ovarian cancer signature2017
Bad phosphorylation determines ovarian cancer chemo-sensitivity and patient surv2016
Bad phosphorylation determines ovarian cancer chemo-sensitivity and patient surv2016
Method and system for data backup2016
Method of predicting chemotherapeutic responsiveness of cancer2016